Fenebrutinib Cut MS Relapses by up to 59% in Clinical Trials
Written by Ted SamsonModerna Begins Testing Vaccine for Epstein-Barr — the Virus That May Be Behind MS
Medically reviewed by Amit M. Shelat, D.O.How Much Do You Know About Supplements for MS?
Medically reviewed by Luc Jasmin, M.D., Ph.D., FRCS (C), FACSBecome a member to get even more